Endoscopic Tissue Cutting and Abdominal Extraction Device vs. Conventional Cold Scalpel
SOLENDO-1
Comparison of Endoscopic Tissue Cutting and Abdominal Extraction Device With Conventional Cold Scalpel
1 other identifier
interventional
84
1 country
1
Brief Summary
The aim of the study is to compare the surgical tissue removal success of the endoscopic tissue cutting device, which was designed by the conductor and developed with the support of TUBITAK-1512 project and for which Turkish and European patent applications were made, with the conventional cold scalpel. Laparoscopic surgeries are performed through incisions ranging from 0.5 cm to 1 cm. After the operation, much larger masses need to be removed from the abdomen compared to these incisions. Currently, in laparoscopic surgery, masses are removed from the abdomen by cutting them into pieces with a scalpel, using electrical devices called power morcellators that are used to cut the tissue/mass with rotational movement and remove it from the abdomen, and directly removing the mass from the abdomen through an incision made as large as the size of the mass. Trying to remove large tissues/mass by dissecting them with a scalpel through incisions that are 1.5-2 cm wide and limit the surgeon's range of motion is quite laborious, tiring, time-consuming and risky. In the use of Power Morcellator disintegrator devices, there is a risk of the pieces of the mass spreading into the abdomen while cutting and separating the tissue/mass that is being removed into small pieces due to the rotational movement in the working principle. In operations where the Power Morcellator device is used, if the removed tissue is malignant (cancerous), the patient faces the risk of metastasis spreading to the entire abdomen. Due to these risks, the use of power morcellator devices has been completely banned in the United States, and in European Union countries, it has been required that the device be operated in protective bags. The invention is a medical device that will allow large masses to be removed quickly, safely and easily through small incisions in closed surgeries. The device offers an effective solution to the problems of the current technique. Within the scope of the study, the morcellator scissors and the scalpel, which are designed and started to be mass-produced, will be compared in the morcellation (removal by separating into pieces) process to be performed during the removal of the mass from the vagina after laparoscopic hysterectomy surgeries, and the morcellation time, possible complications and the possible effects of the device to be used on the case will be investigated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 25, 2024
CompletedFirst Posted
Study publicly available on registry
November 10, 2025
CompletedStudy Start
First participant enrolled
November 13, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 17, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 17, 2026
November 14, 2025
August 1, 2025
10 months
October 25, 2024
November 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Morcellation Time
The time required for complete vaginal morcellation of the uterus, measured from the placement of the uterus into the retrieval bag until complete specimen removal. A shorter duration indicates higher procedural efficiency.
From placement of uterus in retrieval bag to complete removal of specimen, measured in minutes (approximately 0-30 minutes).
Secondary Outcomes (1)
Change in Female Sexual Function Index (FSFI) Score
Baseline (within 1 week before surgery) and 6 months after operation.
Study Arms (2)
Endoscopic Tissue Cutting and Abdominal Extraction Device
EXPERIMENTALIn the cases included in the group, vaginal morcellation will be performed with an endoscopic tissue cutting and removal device after laparoscopic hysterectomy.
Conventional Cold Scalpel
ACTIVE COMPARATORIn the cases included in the group, vaginal morcellation will be performed with a cold scalpel after laparoscopic hysterectomy.
Interventions
Vaginal tissue morcellation after laparoscopic hysterectomy with Endoscopic Tissue Cutting and Abdominal Extraction Device
Vaginal tissue morcellation after laparoscopic hysterectomy with cold scalpel
Eligibility Criteria
You may qualify if:
- Planned laparoscopic hysterectomy
- Estimated uterine weight of 500 g or more
You may not qualify if:
- Sexual inactivity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ege Universitylead
Study Sites (1)
Izmir Bakircay University
Izmir, 35665, Turkey (Türkiye)
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
October 25, 2024
First Posted
November 10, 2025
Study Start
November 13, 2025
Primary Completion (Estimated)
September 17, 2026
Study Completion (Estimated)
December 17, 2026
Last Updated
November 14, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share
Data will not be shared at this stage to protect intellectual property rights related to the patented device. Deidentified data may be made available upon reasonable request after study completion